Drug Trial Radar · NCT04163991
A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis
Last checked: Nov 19, 2026Latest source record: Dec 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
78
Actual
Start
Dec 9, 2019
Primary completion
Dec 28, 2021
Study completion Dec 28, 2021
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Nov 15, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of VIB4920 (formerly MEDI4920) in adult participants with rheumatoid arthritis (RA).
Conditions
- Rheumatoid Arthritis
Interventions
VIB4920Drug
liquid for IV infusion following dilution in normal saline
PlaceboDrug
0.9% saline for IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Day 113 in DAS28-CRPTime frame: Day 1 (Baseline), Day 113
- Number of Participants With Treatment-Emergent Adverse Events (TEAEs), Treatment-Emergent Serious Adverse Events (TESAEs), and Treatment-emergent Adverse Events of Special Interest (TEAESIs)Time frame: From first dose of study drug through Day 309 ± 7 days
Locations
25 sites in 2 countries. Site status is shown where the registry gives one.
Research Site
Anniston, Alabama
Research Site
Sun City, Arizona
Research Site
Upland, California
Research Site
Clearwater, Florida
Research Site
Margate, Florida
Research Site
Miami Lakes, Florida
Research Site
Zephyrhills, Florida
Research Site
Atlanta, Georgia
Research Site
Lexington, Kentucky
Research Site
Wheaton, Maryland
Research Site
Charlotte, North Carolina
Research Site
Rocky Mount, North Carolina
Research Site
Salisbury, North Carolina
Research Site
Vandalia, Ohio
Research Site
Norman, Oklahoma
Research Site
Duncansville, Pennsylvania
Research Site
Baytown, Texas
Research Site
Dallas, Texas
Research Site
Warsaw, Poland
Research Site
Poznan, Greater Poland Voivodeship, Poland
Research Site
Krakow, Lesser Poland Voivodeship, Poland
Research Site
Nadarzyn, Masovian Voivodeship, Poland
Research Site
Siedlce, Masovian Voivodeship, Poland
Research Site
Bialystok, Podlaskie Voivodeship, Poland
Research Site
Elblag, Warmian-Masurian Voivodeship, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.